Trexquant Investment’s Precision BioSciences DTIL Stock Holding History

Trexquant Investment’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$449K	Buy	57,161 +31,095	+119%	+$219K	﹤0.01%	1661
2026 Q1	$143K	Sell	26,066 -14,190	-35%	-$65.5K	﹤0.01%	1689
2025 Q4	$167K	Buy	+40,256	New	+$229K	﹤0.01%	1531
2021 Q3	–	Sell	-815	Closed	-$306K	–	1218
2021 Q2	$306K	Buy	+815	New	+$245K	0.03%	698
2020 Q3	–	Sell	-703	Closed	-$176K	–	1267
2020 Q2	$176K	Buy	703 +55	+8%	+$12K	0.01%	1066
2020 Q1	$117K	Buy	+648	New	+$170K	0.01%	1036

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Trexquant Investment's DTIL Position: Q2 2026 in Review

Trexquant Investment increased its Precision BioSciences (DTIL) stake by 119% in Q2 2026, buying an estimated $219K and bringing the position to 57,161 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #1661.

Trexquant Investment first reported a position in DTIL in Q1 2020 and has held it in 6 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Trexquant Investment held 57,161 shares of Precision BioSciences worth $449K as of Q2 2026.
Trexquant Investment bought 31,095 Precision BioSciences shares in Q2 2026, an estimated $219K.
Precision BioSciences made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1661 holding.
Trexquant Investment first reported a position in Precision BioSciences in Q1 2020 and has held it in 6 quarters since.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.